SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

The World Cup warning: Riots don’t start in the streets. They start online

“There’s a price where you have to say yes”: CyberArk founder on the $25 billion Palo Alto deal

"If there is no significant change, we will see a 25%-30% reduction in high-tech's workforce"

“There is no better solution for Zim than the one we created”

Buzz

Most popular

Daily

Weekly

1

"If an engineer in Ireland costs 20% less, it is clearly part of the consideration when deciding where to expand"

2

Iron Dome and Iron Beam maker Rafael unveils new weapon against the drone threat

3

Echo: “Employees have become very good at identifying performative culture”

4

"If there is no significant change, we will see a 25%-30% reduction in high-tech's workforce"

5

More than 50 years after its debut, Israel's Kfir fighter jet gets a new lease on life

Eli Lilly

2 stories about Eli Lilly

מטה אלי לילי ב אינדיאנפוליס

1,000% stock increase: The story behind Eli Lilly’s pharmaceutical dominance

14.08.24|Viki Auslender

Beating second-quarter forecasts mainly due to its weight loss and diabetes drugs, Eli Lilly, the company aspiring to be worth a trillion dollars, has invested heavily in innovative developments, becoming the pharmaceutical manufacturer with the highest market value in the world.

מעבדה רפואה 1 זירת הבריאות

Eli Lilly Signs Multi-Year Collaboration with Anima Biotech

23.07.18|Lilach Baumer

Israel-based Anima will receive an upfront payment of $30 million and $14 million for research, but could potentially get as much as $1.05 billion in milestones